Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond ER (BEAD-MB) (PMR 2961-9)

NCT04033094 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04033094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04033094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond ER (BEAD-MB) (PMR 2961-9)
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
October 16, 2017
Completion date
December 31, 2020
Enrollment
17,566 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

baseline epidemiologic assessment